Effect of hormonal contraceptive use on HIV progression in female HIV seroconverters in Rakai, Uganda

AIDS

Volumn 24, Issue 12, 2010, Pages 1937-1944

  Polis, Chelsea B ^a   Wawer, Maria J ^a   Kiwanuka, Noah ^c   Laeyendecker, Oliver ^d,e   Kagaayi, Joseph ^b   Lutalo, Tom ^b   Nalugoda, Fred ^b   Kigozi, Godfrey ^b   Serwadda, David ^c   Gray, Ronald H ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b RAKAI HEALTH SCIENCES PROGRAM   (Uganda)

^c MAKERERE UNIVERSITY SCHOOL OF PUBLIC HEALTH   (Uganda)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Family planning; HIV progression; Hormonal contraception; Survival analysis; Uganda

Indexed keywords

CONTRACEPTIVE AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; CONFIDENCE INTERVAL; DISEASE COURSE; FEMALE; HAZARD RATIO; HORMONAL CONTRACEPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; UGANDA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CONFIDENCE INTERVALS; CONTRACEPTIVES, ORAL, HORMONAL; DISEASE PROGRESSION; FEMALE; HIV SEROPOSITIVITY; HIV-1; HUMANS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; UGANDA; YOUNG ADULT;

EID: 77954761480     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32833b3282     Document Type: Article

References (31)

1. Cates W Jr. Use of contraception by HIV-infected women. IPPF Med Bull 2001; 35:1-3.
2. Shah I. Contraceptive use patterns in countries with different levels of HIV epidemic. J Acquir Immune Defic Syndr 2005; 38 (Suppl 1):S5-S6.
3. United Nations. World contraceptive use 2007. New York, USA: United Nations; 2008.
4. Reynolds HW, Steiner MJ, Cates W Jr. Contraception's proved potential to fight HIV. Sex Transm Infect 2005; 81:184-185.
5. Arrive E, Newell ML, Ekouevi DK, Chaix ML, Thiebaut R, Masquelier B, et al. Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis. Int J Epidemiol 2007; 36:1009-1021.
6. Kumar RM, Uduman SA, Khurrana AK. Impact of pregnancy on maternal AIDS. J Reprod Med 1997; 42:429-434.
7. Van der Paal L, Shafer LA, Mayanja BN, Whitworth JAG, Grosskurth H. Effect of pregnancy on HIV disease progression and survival among women in rural Uganda. Trop Med Int Health 2007; 12:920-928.
8. Breastfeeding and HIV International Transmission Study Group. Mortality among HIV-1-infected women according to children's feeding modality: an individual patient data meta-analysis. J Acquir Immune Defic Syndr 2005; 39:430-438.
9. Coutsoudis A, Coovadia H, Pillay K, Kuhn L. Are HIV-infected women who breastfeed at increased risk of mortality? AIDS 2001; 15:653-655.
10. Kuhn L,Kasonde P, Sinkala M, Kankasa C, Semrau K, Vwalika C, et al. Prolonged breast-feeding and mortality up to two years postpartum among HIV-positive women in Zambia. AIDS 2005; 19:1677-1681.
11. Nduati R, Richardson BA, John G, Mbori-Ngacha D, Mwatha A, Ndinya-Achola J, et al. Effect of breastfeeding on mortality among HIV-1 infected women: a randomised trial. Lancet 2001; 357:1651-1655.
12. Taha TE, Kumwenda NI, Hoover DR, Kafulafula G, Fiscus SA, Nkhoma C, et al. The impact of breastfeeding on the health of HIV-positive mothers and their children in sub-Saharan Africa. Bull World Health Organ 2006; 84:546-554.
13. Stringer EM, Kaseba C, Levy J, Sinkala M, Goldenberg RL, Chi BH, et al. A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus. Am J Obstet Gynecol 2007; 197:144-148.
14. Stringer EM, Levy J, Sinkala M, Chi BH, Matongo I, Chintu N, et al. HIV disease progression by hormonal contraceptive method: secondary analysis of a randomized trial. AIDS 2009; 23:1377-1382.
15. Sagar M, Lavreys L, Baeten JM, Richardson BA, Mandaliya K, Ndinya-Achola JO, et al. Identification of modifiable factors that affect the genetic diversity of the transmitted HIV-1 population. AIDS 2004; 18:615-619.
16. Baeten JM, Lavreys L, Sagar M, Kreiss JK, Richardson BA, Chohan B, et al. Effect of contraceptive methods on natural history of HIV: studies from the Mombasa cohort. J Acquir Immune Defic Syndr 2005; 38 (Suppl 1):S18-S21.
17. Lavreys L, Baeten JM, Kreiss JK, Richardson BA, Chohan BH, Hassan W, et al. Injectable contraceptive use and genital ulcer disease during the early phase of HIV-1 infection increase plasma virus load in women. J Infect Dis 2004; 189:303-311.
18. Lavreys L, Chohan V, Overbaugh J, Hassen W, McClelland RS, Kreiss J, et al. Hormonal contraception and risk of cervical infections among HIV-1-seropositive Kenyan women. AIDS 2004; 18:2179-2184.
19. Patterson BK, Landay A, Andersson J, Brown C, Behbahani H, Jiyamapa D, et al. Repertoire of chemokine receptor expression in the female genital tract: implications for human immunodeficiency virus transmission. Am J Pathol 1998; 153:481-490. (Pubitemid 28373659)
20. Prakash M, Kapembwa MS, Gotch F, Patterson S. Oral contraceptive use induces upregulation of the CCR5 chemokine receptor on CD4(R) T cells in the cervical epithelium of healthy women. J Reprod Immunol 2002; 54:117-131.
21. Hunt JS, Miller L, Platt JS. Hormonal regulation of uterine macrophages. Dev Immunol 1998; 6:105-110.
22. Trunova N, Tsai L, Tung S, Schneider E, Harouse J, Gettie A, et al. Progestin-based contraceptive suppresses cellular immune responses in SHIV-infected rhesus macaques. Virology 2006; 352:169-177.
23. Allen S, Stephenson R, Weiss H, Karita E, Priddy F, Fuller L, et al. Pregnancy, hormonal contraceptive use, and HIV-related death in Rwanda. J Womens Health 2007; 16:1017-1027.
24. Curtis KM, Nanda K, Kapp N. Safety of hormonal and intrauterine methods of contraception for women with HIV/AIDS: a systematic review. AIDS 2009; 23 (Suppl 1):S55-S67.
25. Wawer MJ, Gray RH, Sewankambo NK, Serwadda D, Paxton L, Berkley S, et al. A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda. AIDS 1998; 12:1211-1225.
26. Wawer MJ, Sewankambo NK, Serwadda D, Quinn TC, Paxton LA, Kiwanuka N, et al. Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group. Lancet 1999; 353:525-535.
27. Wawer MJ, Serwadda D, Gray RH, Sewankambo NK, Li C, Nalugoda F, et al. Trends in HIV-1 prevalence may not reflect trends in incidence in mature epidemics: data from the Rakai population-based cohort, Uganda. AIDS 1997; 11:1023-1030.
28. Sewankambo NK, Gray RH, Ahmad S, Serwadda D, Wabwire-Mangen F, Nalugoda F, et al. Mortality associated with HIV infection in rural Rakai District, Uganda. AIDS 2000; 14:2391-2400.
29. WHO. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. 2006.
30. Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika 1982; 69:239-241.
31. Fisher LD, Lin DY. Timedependent covariates in the Cox proportional-hazards regression model. Annu Rev Public Health 1999; 20:145-157.